SANUWAVE Health, Inc.  

(Public, OTCMKTS:SNWV)   Watch this stock  
Find more results for snwv
0.165
-0.004 (-2.25%)
After Hours: 0.153 -0.012 (-7.15%)
Feb 24, 4:13PM EST  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.15 - 0.17
52 week 0.03 - 0.20
Open 0.16
Vol / Avg. 586,646.00/203,462.00
Mkt cap 22.62M
P/E     -
Div/yield     -
EPS -0.06
Shares 137.10M
Beta 0.54
Inst. own 0%
Mar 28, 2017
Q4 2016 SANUWAVE Health Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
  

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -445.85% -498.22%
Operating margin -326.07% -459.64%
EBITD margin - -437.85%
Return on average assets -493.89% -171.04%
Return on average equity - -
Employees 8 -
CDP Score - -

Address

3360 Martin Farm Rd Ste 100
SUWANEE, GA 30024-2292
United States - Map
+1-770-4197525 (Phone)
+1-770-4198634 (Fax)

Website links

Description

SANUWAVE Health, Inc. is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, enabling to restore the body's normal healing processes and regeneration. It is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Lisa E. Sundstrom Chief Financial Officer
Age: 45
John F. Nemelka Director
Age: 49
A. Michael Stolarski Director
Alan L. Rubino Independent Director
Age: 60